Historical Stock Price
ETFs Holding VRTX »    VRTX Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
10/10/2019 $168.42 $170.37 $167.62 $170.22 765.60K
10/11/2019 $171.44 $174.72 $171.13 $172.41 854.90K
10/14/2019 $172.32 $175.25 $172.32 $173.59 540.60K
10/15/2019 $174.36 $176.98 $174.02 $176.14 738.80K
10/16/2019 $175.32 $177.20 $173.62 $176.09 749.40K
Vertex Pharmaceuticals is engaged in developing and commercializing therapies for the treatment of cystic fibrosis (CF). Co.'s marketed medicines are SYMDEKO/SYMKEVI (tezacaftor in combination with ivacaftor), ORKAMBI (lumacaftor in combination with ivacaftor) and KALYDECO (ivacaftor), which are approved to treat patients with CF who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene. Co. is developing VX-150, a NaV1.8 inhibitor, as a potential treatment for pain. Co. is co-developing CTX001, an investigational gene editing treatment, for the treatment of beta-thalassemia and sickle cell disease, with CRISPR Therapeutics AG.
VRTX historical stock prices picture
Vertex Pharmaceuticals (VRTX) has the following price history information. Looking back at VRTX historical stock prices for the last five trading days, on October 10, 2019, VRTX opened at $168.42, traded as high as $170.37 and as low as $167.62, and closed at $170.22. Trading volume was a total of 765.60K shares. On October 11, 2019, VRTX opened at $171.44, traded as high as $174.72 and as low as $171.13, and closed at $172.41. Trading volume was a total of 854.90K shares. On October 14, 2019, VRTX opened at $172.32, traded as high as $175.25 and as low as $172.32, and closed at $173.59. Trading volume was a total of 540.60K shares. On October 15, 2019, VRTX opened at $174.36, traded as high as $176.98 and as low as $174.02, and closed at $176.14. Trading volume was a total of 738.80K shares. On October 16, 2019, VRTX opened at $175.32, traded as high as $177.20 and as low as $173.62, and closed at $176.09. Trading volume was a total of 749.40K shares.

VRTX Historical Stock Prices By Date:

VRTX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vertex Pharmaceuticals shares, starting with a $10,000 purchase of VRTX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/19/2009
End date: 10/16/2019
Start price/share: $34.83
End price/share: $176.09
Dividends collected/share: $0.00
Total return: 405.57%
Average Annual Total Return: 17.60%
Starting investment: $10,000.00
Ending investment: $50,568.53
Years: 10.00
Date Close
10/10/2019$170.22
10/11/2019$172.41
10/14/2019$173.59
10/15/2019$176.14
10/16/2019$176.09
VRTX is categorized under the Healthcare sector; below are some other companies in the same sector:

VRX Historical Stock Prices
VSAR Historical Stock Prices
VSCI Historical Stock Prices
VSCP Historical Stock Prices
VSTM Historical Stock Prices
VTAE Historical Stock Prices
VTGN Historical Stock Prices
VTL Historical Stock Prices
VTUS Historical Stock Prices
VTVT Historical Stock Prices

Also explore: VRTX shares outstanding history

VRTX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.